Intraperitoneal Carboplatin Prolongs PFS After Surgery in Ovarian Cancer
Intraperitoneal carboplatin can prolong progression-free survival, but not overall survival, in patients with ovarian cancer.
Society of Gynecologic Oncology (SGO)
1 in 20 Gynecologic Cancer Patients Die Within 30 Days of COVID-19 Diagnosis
In a registry-based study, 5% of patients with gynecologic cancer died within 30 days of COVID-19 diagnosis.
‘Alarming’ Trend in Uterine Cancer Incidence: High-Risk Histologies on the Rise
The trend may be partially explained by increasing obesity rates, according to researchers.
Black, Hispanic Patients Underrepresented in Trials Supporting Guidelines for Endometrial Cancer
Black and Hispanic patients are underrepresented in studies supporting NCCN guidelines for endometrial cancer.
Olaparib Did Not Improve PFS2, OS in SOLO3 Trial
Olaparib did improve the time to subsequent treatment and time to discontinuation or death.
Tool Predicts Need for Blood Transfusion Due to Ovarian Cancer Surgery
The tool, called the “BLOODS score,” was developed to help identify patients who may benefit from preoperative planning and blood-saving techniques.
Study on Lenvatinib Overspending Prompts Manufacturer Promise of Dose Exchange Revamp
Data on overspending due to lenvatinib’s dose-specific packaging prompted the drug’s manufacturer to commit to changing its dose exchange program.
Cervical Cancer Screening Guidelines: Time for a Change?
It may be time to revise US screening guidelines for cervical cancer in patients age 65 and older, according to researchers.
Sexual Orientation Does Not Impact Risk of HPV Infection in Women
New data suggest that, contrary to popular belief, lesbian or bisexual women have a similar risk of HPV infection as heterosexual women.
Adjuvant Chemo May Not Improve OS in Low-Grade Serous Ovarian Carcinoma
The 4-year overall survival rate was similar with adjuvant chemotherapy and without it.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in SGO 2022
Loading... 
Loading...